An infusion center that will provide antibody treatments for COVID-19 patients is opening in Victoria on Wednesday.

The 10-bed facility will be able to treat about 30 to 40 patients a day. It will be open from 8 a.m. to 5 p.m. daily.

Francisco Garcia, project manager with Ashbritt Logistics, gives a tour of the new antibody infusion treatment center opening in Victoria on Wednesday. The COVID-19 treatments will be available for about 30 to 40 patients per day, and the facility's capacity could double if needed, Garcia said.

Recommended For You

Mark Rosenberg reports on local, regional and breaking news for the Victoria Advocate as a Report for America corps member. He can be reached at or 361-574-1264 or on Twitter at @markrosenberg32. To support local journalism at the Advocate through Report for America, go to

You must be logged in to react.
Click any reaction to login.

(1) comment

JoPatric Love

I'm glad there are treatment options available BUT Monoclonal Antibody Treatment is significantly more costly than the vaccine, takes longer to administer and isn't proven to be more effective long term.

Regeneron is selling its monoclonal antibody cocktail to the U.S. government at $2,100 per dose, the same price as Eli Lilly's treatment. That's about 52 times more than the cost of two doses of the Pfizer vaccine.

Demand for monoclonal antibody treatments have surged as the Delta variant spreads, but hordes of Americans relying on the treatment instead of vaccination is an expensive solution to the pandemic.

A free and effective way of helping to keep COVID-19-positive people out of the hospital, states ramped up access to monoclonal antibody treatments. Amid increased interest, the Biden administration purchased another 1.4 million doses of Regeneron's monoclonal antibody treatment, but the move to fight off a potential shortage of the treatment came at a cost of nearly $3 billion.

Regeneron is selling its monoclonal antibody cocktail to the U.S. government at $2,100 per dose, the same price as Eli Lilly's treatment.

The only COVID-19 vaccine to be fully approved by the Food and Drug Administration, Pfizer sold its vaccine to the Trump administration in July 2020 for about $19.50 per dose. A two-dose vaccine, the inoculation costs about $40 per person. Moderna's vaccine is priced at about $15 per dose, a total of about $30 for full vaccination, and Johnson & Johnson's one-dose vaccine was only about $10 per dose, according to the Congressional Research Service.

Welcome to the discussion.

Transparency. Your full name is required.
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article. And receive photos, videos of what you see.
Don’t be a troll. Don’t be a troll. Don’t post inflammatory or off-topic messages, or personal attacks.

Thank you for reading!

Please log in, or sign up for a new account and purchase a subscription to read or post comments.

To subscribe, click here. Already a subscriber? Click here.